Could Sirius XM Holdings Inc (SIRI) Stock Recover or Take a Sudden Dip? Here’s What to Watch
Wolfe Research has recently raised Plains GP Holdings LP (PAGP) stock to Outperform rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 18, 2024, Wells Fargo had reduced the stock from a Overweight to Equal Weight, setting a price target of $20 for PAGP stock. Morgan Stanley also reduced rating with […]
Plains GP Holdings LP (PAGP) Stock’s 0.15% Increase This Year: What’s the Story?
Wolfe Research has recently raised Plains GP Holdings LP (PAGP) stock to Outperform rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 18, 2024, Wells Fargo had reduced the stock from a Overweight to Equal Weight, setting a price target of $20 for PAGP stock. Morgan Stanley also reduced rating with […]
Plains GP Holdings LP (PAGP)’s Stock Surge: What You Need to Know
Wolfe Research has recently raised Plains GP Holdings LP (PAGP) stock to Outperform rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 18, 2024, Wells Fargo had reduced the stock from a Overweight to Equal Weight, setting a price target of $20 for PAGP stock. Morgan Stanley also reduced rating with […]
The Plains GP Holdings LP Enigma: What’s Causing the Wild Swings in PAGP Stock?
Wolfe Research has recently raised Plains GP Holdings LP (PAGP) stock to Outperform rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 18, 2024, Wells Fargo had reduced the stock from a Overweight to Equal Weight, setting a price target of $20 for PAGP stock. Morgan Stanley also reduced rating with […]
Plains GP Holdings LP (PAGP) Stock Settles at $20.67: What’s Contributing to This Price Point?
Wolfe Research has recently raised Plains GP Holdings LP (PAGP) stock to Outperform rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 18, 2024, Wells Fargo had reduced the stock from a Overweight to Equal Weight, setting a price target of $20 for PAGP stock. Morgan Stanley also reduced rating with […]
Plains GP Holdings LP (PAGP) Reported a 3.39% Operating Margin Last Year—What’s the Real Story?
Wolfe Research has recently raised Plains GP Holdings LP (PAGP) stock to Outperform rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 18, 2024, Wells Fargo had reduced the stock from a Overweight to Equal Weight, setting a price target of $20 for PAGP stock. Morgan Stanley also reduced rating with […]
What Factors Have Led to Plains GP Holdings LP (PAGP) Stock Trading -0.85% Below Its 52-Week High?
Wells Fargo has recently reduced Plains GP Holdings LP (PAGP) stock to Equal Weight rating, as announced on December 18, 2024, according to Finviz. Earlier, on October 25, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $19 for PAGP stock. Scotiabank also resumed Sector Outperform rating with a price target […]
Wells Fargo Just Downgraded Plains GP Holdings LP (PAGP) Stock—What Does This Mean for Investors?
Wells Fargo has recently reduced Plains GP Holdings LP (PAGP) stock to Equal Weight rating, as announced on December 18, 2024, according to Finviz. Earlier, on October 25, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $19 for PAGP stock. Scotiabank also resumed Sector Outperform rating with a price target […]
Plains GP Holdings LP (PAGP) Stock: Greater Than Its Current Valuation?
Wells Fargo has recently reduced Plains GP Holdings LP (PAGP) stock to Equal Weight rating, as announced on December 18, 2024, according to Finviz. Earlier, on October 25, 2024, Morgan Stanley had reduced the stock rating, setting a price target of $19 for PAGP stock. Scotiabank also resumed Sector Outperform rating with a price target […]
Why Did Plains GP Holdings LP (PAGP) Stock Rise 0.16% to $19.32?
Morgan Stanley has recently reduced Plains GP Holdings LP (PAGP) stock rating, as announced on October 25, 2024, according to Finviz. Earlier, on April 8, 2024, Scotiabank had resumed the stock to Sector Outperform, setting a price target of $23. Goldman also resumed Sell rating with a price target of $13.50. Additionally, Barclays reduced Underweight […]